In cells from aged individuals, Livagen showed corrective activity in the adaptive-response experiment.
In plain wordsIn cells from older people, Livagen showed corrective activity in the adaptive-response experiment.
- Peptide
- Livagen (KEDA)
- Outcome
- Direction not reportedCorrection of adaptive response
- Study
humann: not reported in source
PHA-stimulated cells from old individuals- Outcome group
- Receptor activity and mechanism · Whole body
- Studied dose
- Dose not stated
Source sentences
Corrective activity of Livagen was observed.
2 context sentences(design, population, supporting numbers)
PHA-stimulated cells were from 72-86 year-old individuals; control - 30-40 year-old individuals.
The correcting activity of the peptide bioregulator Livagen was tested.